TRPC6 and kidney disorder: Importantly, a member of the same TRPC6 inhibitor class has been tested in humans (healthy men, NCT04665700, NCT03854552; renal disease, NCT04176536; and COVID-19, NCT04604184), enhancing the translational significance of our findings.